Laboratory Corporation of America Holdings Stock price

Equities

LH

US50540R4092

Healthcare Facilities & Services

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
218.5 USD +0.87% Intraday chart for Laboratory Corporation of America Holdings +3.39% -3.88%
Sales 2024 * 12.76B Sales 2025 * 13.29B Capitalization 18.21B
Net income 2024 * 1B Net income 2025 * 1.13B EV / Sales 2024 * 1.77 x
Net Debt 2024 * 4.35B Net Debt 2025 * 3.86B EV / Sales 2025 * 1.66 x
P/E ratio 2024 *
18.4 x
P/E ratio 2025 *
16.4 x
Employees 61,975
Yield 2024 *
1.37%
Yield 2025 *
1.41%
Free-Float 99.74%
More Fundamentals * Assessed data
Dynamic Chart
Laboratory Corp of America to Acquire BioReference's Diagnostics Business Select Assets MT
Laboratory Corporation of America Holdings (NYSE:LH) entered into an Asset Purchase Agreement to acquire Select Assets of BioReference Health, LLC for approximately $240 million. CI
North American Morning Briefing : Markets Steady -2- DJ
Argus Upgrades Laboratory Corp of America Holdings to Buy From Hold, Price Target is $250 MT
Laboratory Corp of America Launches PTau217 Diagnostic Test for Alzheimer's Disease MT
Labcorp Introduces New Biomarker Test for Alzheimer's Disease MT
Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials CI
Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-Targeted Therapies for Patients with Epithelial Ovarian Cancer CI
Laboratory Corp Of America Holdings Insider Sold Shares Worth $1,102,736, According to a Recent SEC Filing MT
Labcorp Launches Weight Loss Management Testing Solutions CI
Pinnacle Fertility Partners with Labcorp to Advance Genetic Testing Services CI
Leerink Partners Initiates Coverage on Laboratory Corp of America With Outperform Rating, $260 Price Target MT
Laboratory Corp Of America Holdings Insider Sold Shares Worth $7,451,866, According to a Recent SEC Filing MT
Deutsche Bank Raises Laboratory Corp of America Price Target to $220 From $215, Maintains Hold Rating MT
Laboratory Corporation of America Holdings to Seek Acquisitions CI
More news

Latest transcript on Laboratory Corporation of America Holdings

1 day+0.41%
1 week+3.03%
Current month+0.87%
1 month+1.35%
3 months-4.12%
6 months+7.10%
Current year-4.22%
More quotes
1 week
210.19
Extreme 210.19
217.91
1 month
206.37
Extreme 206.37
221.14
Current year
206.37
Extreme 206.37
234.09
1 year
195.01
Extreme 195.01
243.30
3 years
195.01
Extreme 195.01
317.17
5 years
98.02
Extreme 98.02
317.17
10 years
95.12
Extreme 95.12
317.17
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 13-03-31
Director of Finance/CFO 62 14-06-15
Compliance Officer 65 19-01-31
Members of the board TitleAgeSince
Director/Board Member 75 07-05-15
Chief Executive Officer 59 13-03-31
Director/Board Member 74 95-04-27
More insiders
Date Price Change Volume
24-03-28 218.5 +0.87% 607 581
24-03-27 216.6 +1.43% 430,701
24-03-26 213.5 -0.11% 559,147
24-03-25 213.8 +0.23% 520,476
24-03-22 213.3 +0.93% 806,721

Delayed Quote Nyse, March 28, 2024 at 12:23 pm EDT

More quotes
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies. Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
216.6 USD
Average target price
244.9 USD
Spread / Average Target
+13.07%
Consensus
  1. Stock
  2. Equities
  3. Stock Laboratory Corporation of America Holdings - Nyse